Patents/Assignees

Inhibrx Biosciences, Inc.

13 patents in portfolio

US12590169utility2026
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
0 cites
US12552855utility2026
CD33 Targeted Immunotherapies
0 cites
US12421315utility2025
CLL-1 Targeted Immunotherapies
0 cites
US12365728utility2025
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
0 cites
US12331126utility2025
Ox40-binding Polypeptides and Uses Thereof
0 cites
US12331132utility2025
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
0 cites
US12297271utility2025
PD-1 Single Domain Antibodies and Therapeutic Compositions Thereof
0 cites
US12234297utility2025
Ige Binding Proteins and Uses Thereof
0 cites
US12227584utility2025
Multivalent and Multispecific Ox40-binding Fusion Proteins
0 cites
US12195533utility2025
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Receptor Binding Region and Methods of Using the Same
0 cites
US12187804utility2025
Multivalent and Multispecific 41bb-binding Proteins
0 cites
US12084502utility2024
Cd33-binding Polypeptides and Uses Thereof
0 cites
US12043667utility2024
Clec12a Binding Polypeptides and Uses Thereof
0 cites